Zobrazeno 1 - 10
of 175
pro vyhledávání: '"César Serrano"'
Publikováno v:
Revista de Estudios Socioeducativos, Vol 1, Iss 12 (2024)
El desarrollo de estrategias de marketing está permitiendo cubrir las necesidades de las entidades en el mundo del fútbol y con ello la fidelización de sus fans. En este estudio, se analiza la utilización de las redes sociales por parte de las en
Externí odkaz:
https://doaj.org/article/760454be817b476da7b47bf8c2fb5d00
Autor:
Francisco Cristóbal Muñoz-Casares, Javier Martín-Broto, Pedro Cascales-Campos, Juan Torres-Melero, Irene López-Rojo, José Gómez-Barbadillo, Luis González-Bayón, Ana Sebio, César Serrano, Sara Carvalhal, Joaquim Abreu de Souza, Alexandre Souza, Guillermo Flores-Ayala, Luis José Palacios Fuenmayor, Raquel Lopes-Bras, José Antonio González-López, Hugo Vasques, José Manuel Asencio-Pascual
Publikováno v:
Cancers, Vol 16, Iss 15, p 2646 (2024)
Peritoneal sarcomatosis is a rare malignant disease with a poor prognosis, secondary to peritoneal dissemination of abdominopelvic soft tissue sarcomas. Its rarity, together with the characteristic histological heterogeneity and the historically poor
Externí odkaz:
https://doaj.org/article/4942600dd9c24c028aa9528483b9b0d5
Autor:
Bruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa e Silva, Rodrigo Dienstmann, Carlos Gil Ferreira, César Serrano
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEMutations of the KIT gene are the molecular hallmark of most GI stromal tumors (GISTs). Imatinib has revolutionized GIST treatment. Adjuvant imatinib for 3 years is the standard of care for high-risk resected GIST. However, the GIST molecular
Externí odkaz:
https://doaj.org/article/73f84fe9ba8a4e9b9b0f15018479bb0c
Autor:
Patrick Schöffski, Suzanne George, Michael C. Heinrich, John R. Zalcberg, Sebastian Bauer, Hans Gelderblom, César Serrano, Robin L. Jones, Steven Attia, Gina D’Amato, Ping Chi, Peter Reichardt, Claus Becker, Kelvin Shi, Julie Meade, Rodrigo Ruiz-Soto, Jean-Yves Blay, Margaret von Mehren
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Ripretinib is a novel switch-control kinase inhibitor that inhibits KIT and PDGFRA signaling. In the INVICTUS phase 3 trial, ripretinib increased median progression-free survival and prolonged overall survival vs. placebo in ≥ f
Externí odkaz:
https://doaj.org/article/9bb5658e944d433ba93df74a037e4505
Autor:
Albert Manzano-Muñoz, José Yeste, María A. Ortega, Fernando Martín, Anna López, Jordi Rosell, Sandra Castro, César Serrano, Josep Samitier, Javier Ramón-Azcón, Joan Montero
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract Precision medicine is starting to incorporate functional assays to evaluate anticancer agents on patient-isolated tissues or cells to select for the most effective. Among these new technologies, dynamic BH3 profiling (DBP) has emerged and ex
Externí odkaz:
https://doaj.org/article/ea5cfae12fc44f92bd5c6ab6988a1a76
Autor:
César Serrano, Javier Martín-Broto, José Manuel Asencio-Pascual, José Antonio López-Guerrero, Jordi Rubió-Casadevall, Silvia Bagué, Xavier García-del-Muro, Juan Ángel Fernández-Hernández, Luís Herrero, Antonio López-Pousa, Andrés Poveda, Virginia Martínez-Marín
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of mesenchymal origin. GIST spans a wide clinical spectrum that ranges from tumors with essentially no metastatic potential to malignant and life-threatening spread diseases.
Externí odkaz:
https://doaj.org/article/e6ecb7a4ddf8467782b9f75b726ff046
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundThe development of novel therapies for patients with sarcoma is challenging due to the rarity and diversity of these mesenchymal neoplasms. Hence, histology-agnostic approvals can be of particular interest for the treatment of patients with
Externí odkaz:
https://doaj.org/article/7bbdbba71afb40c185bfae04036fc717
Autor:
Salomé Ruiz-Demoulin, Eva Trenquier, Sanaa Dekkar, Sébastien Deshayes, Prisca Boisguérin, César Serrano, Pascal de Santa Barbara, Sandrine Faure
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7138 (2023)
Gastrointestinal stromal tumor (GIST), the most common sarcoma, is mainly caused by an oncogenic mutation in the KIT receptor tyrosine kinase. Targeting KIT using tyrosine kinase inhibitors, such as imatinib and sunitinib, provides substantial benefi
Externí odkaz:
https://doaj.org/article/c1c5993437a24523a82491dffaa89ac5
Autor:
Diego Gómez-Carmona, Serafín Cruces-Montes, Pedro Pablo Marín-Dueñas, César Serrano-Domínguez, Alberto Paramio, Antonio Zayas García
Publikováno v:
Journal of Theoretical and Applied Electronic Commerce Research, Vol 16, Iss 5, Pp 1648-1666 (2021)
The nature of e-commerce prevents the perception of the intrinsic and sensory attributes of wine. In the virtual environment, visual cues allow consumers to perceive the product, determine their attitude and form a preference. Users will choose one p
Externí odkaz:
https://doaj.org/article/695e588c35d44788b2c7d99e5402491d
Autor:
Juan A. Fernández-Hernández, Sonia Cantín-Blázquez, Elena García-Somacarrera, Evaristo Varo-Pérez, José A. González-López, José M. Asencio-Pascual, Marta Mendiola, César Serrano, Eduardo García-Granero, Vicente Artigas-Raventós
Publikováno v:
Cirugía y Cirujanos, Vol 90, Iss 2 (2022)
Los tumores del estroma gastrointestinal (GIST) suponen el 1-2% de los tumores digestivos, siendo su localización más frecuente el estómago (55-60%) y el intestino delgado (30%). Los avances más importantes sucedidos en los últimos años se cent
Externí odkaz:
https://doaj.org/article/131b8b10bfb44d17b36db40ae643a188